CB
Cue Biopharma, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise4count reported to the SEC
FiledJul 22, 2026first sale Jul 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dominic BorieExecutive Officer
Daniel CamardoDirector
Sumita RayExecutive Officer
Pamela GarzoneDirector
Viola MeehanDirector
Shao-Lee LinExecutive Officer, Director
Pasha SarrafDirector
Michael MeluzioExecutive Officer
Executive officers, directors and promoters as listed on the Form D.